chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 3 months after having the vaccine administered, I began having intensive itching on my scalp. These symptoms began in May. I also started taking Tremfya in March of 2022. I thought that the itching was due to scalp psoriasis. I contacted my doctor, and she suggested that I treat it with a steroid shampoo called Clobetasol. I used the shampoo every other day, but my symptoms did not improve. I also developed itching on my back. I treated it with over-the-counter Hydrocortisone cream. It helped but did not make it go away. In August I had a n appointment with a dermatologist for my back and he prescribed a stronger steroid cream called Mometasone. This cream did not get rid of the symptoms. In October I saw a new PCP and told her my story. She prescribed Ketoconnozole cream. I also use Ketoconnozole shampoo, and the symptoms got much better over the 2-to-3-month period. I don't believe my symptoms have resolved. I saw a dermatologist in January 2023, and I was diagnosed with having Folliculitis.
Patient received original pfizer formulation instead of bivalent. CDC recommended no action may receive bivalent in 2 months.
Information has been received from a registered nurse regarding an unknown age and gender patient. On 08-DEC-2011 at 8:00, ZOSTAVAX, (Lot # 671140/1266AA) was exposed to -13 degrees C for an estimated total time out of range of 10.5 hours. On 28-DEC-2011, the patient was administered an out of range dose of ZOSTAVAX (Lot # 671140/1266AA, expiration date 05-NOV-2012) (dose and route of administration were not provided). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
I had a very extreme flare up of my psoriasis condition on my feet; This is a spontaneous report from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 64-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Nov2021 at 15:00 (Lot number: FJ1611) at the age of 64 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Anxiety" (unspecified if ongoing) and "Psoriasis" (ongoing). Concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot Number: EW0153; Anatomical Location: Left arm; Administration time: 15:00), administration date: 09Apr2021, when the patient was 64 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE; Lot Number: EW0179; Anatomical Location: Left arm; Administration time: 15:00), administration date: 30Apr2021, when the patient was 64 years old, for COVID-19 immunisation.  The following information was reported: PSORIASIS (non-serious) with onset 06Dec2021, outcome "recovered with sequelae", described as "I had a very extreme flare up of my psoriasis condition on my feet". The event "I had a very extreme flare up of my psoriasis condition on my feet" was evaluated at the physician office visit. Therapeutic measures were taken as a result of psoriasis.  Additional Information: The patient had no known allergies which he was aware of. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Treatment included unspecified topical ointment for psoriasis. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Sunday, Jan 24th 2:22 am - woke to violent, uncontrollable chills/shivers - lasted for 8 minutes before stopping. Severe migraine-level headache.  6:30 am - thoracic muscle pain/soreness, occasional chills continued, axillary temp 100.4 F. 17:35 pm - repeat episode of violent chills/shivering - lasted for 5 minutes, severe headache continued, axillary temp 101.8 F. Monday, Jan 25th 3:30 - woke with continued severe headache and mild chills. Axillary temp 100 F.
Got his vaccine,  stayed 30 minutes, had no problems.  He went to bed, woke up and has mild persistent headache, mild persistent fever, achiness, body aches all over, flu-like symptoms, not much appetite.   He did take Ibuprofen for the symptoms and is starting to feel a little better.  The headache is gone, the arm is less sore.
Persistent headaches, shortness of breathe, body aches, fatigue, sharp chest pain
Body aches overnight then a spell of dizziness, nausea and almost fainting and sweating profusely around 9:30am the following day. Continued body aches and headache for remainder of the day.
Child had rash started on back of legs, back, hands and face and child c/o itching. Dad states it did improve but now worse 2 days after vaccines.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that the data logger that caller was unable to download were for the months of Dec-2021, Jan-2022, and Feb-2022. The reporter also stated that no adverse reactions were reported by any patients. The reporter reiterated that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion.  No treatment medications were reported.
(L) deltoid with redness, warmth, swelling. Mom gave BENADRYL and applied ice pack.
Mother called health department o 8/5/2016 requesting VAERS submission. Had not planned on having child immunized with all vaccines at one time and was considering delayed schedule. Ex husband brought child in for immunizations and consented to all. Mother states child began experiencing decreased immune system. Frequent illness and is now cognitively delayed.
2 days after the vaccine,  04/26/2021  I had severe itching all over my body.  There were rashes, redness and flushing on my face.  I took antihistamines such as Benadryl, Flonase and Claritin.  The itching and rashes would only subside for a bit then come back. On day 7,  05/03/2021  doctor gave me Methylprednisolone  6-day pack. There was some improvement today at Day 2.  I really don't want to be on steroids but I haven't slept for a week now. I do not think I will get that booster shot.   I am telling my friends and relatives not to get Moderna.
This case was reported by a physician via sales rep and described the occurrence of generalized rash in a 18-year-old  male patient who received MENVEO. Co-suspect products included Hepatitis A vaccine. Previously administered products included DTAP with an associated reaction of adverse reaction (received on an unknown date, at an age of 15 months, see case US2016GSK154263). In September 2016, the patient received MENVEO and Hepatitis A vaccine. In September 2016, 1 day after receiving MENVEO and Hepatitis A vaccine, the patient experienced generalized rash. On an unknown date, the outcome of the generalized rash was recovered/resolved. The reporter considered the generalized rash to be almost certainly related to MENVEO and Hepatitis A vaccine. Additional details were provided as follows: This case was reported by the patient's father was also a physician. The age at vaccination was not reported. The patient experienced body rash after receiving MENVEO and Hepatitis A vaccine (unknown manufacturer). Limited details were available.
Sudden lightheadedness beginning at 11:30am on 9/12/17, decreasing balance/stability, some difficulty focusing. Symptoms increasing. Went to the Emergency Department thinking she was developing a stroke, CT scan, Carotid ultrasound, EKG, labs all normal range. Symptoms eased after 3-4 hours. She went home and took the next day off of work due to lightheadedness and difficulty focusing.
fever; out of breath; chills; fatigue; body aches; Headache; swelling under the armpit; Patient experienced arm pain 30 minutes after receiving the dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Patient experienced arm pain 30 minutes after receiving the dose), PYREXIA (fever), DYSPNOEA (out of breath), CHILLS (chills) and FATIGUE (fatigue) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. C18B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PAIN IN EXTREMITY (Patient experienced arm pain 30 minutes after receiving the dose). On 26-Mar-2021, the patient experienced PYREXIA (fever), DYSPNOEA (out of breath), CHILLS (chills), FATIGUE (fatigue), MYALGIA (body aches), HEADACHE (Headache) and LYMPHADENITIS (swelling under the armpit). At the time of the report, PAIN IN EXTREMITY (Patient experienced arm pain 30 minutes after receiving the dose), PYREXIA (fever), DYSPNOEA (out of breath), CHILLS (chills), FATIGUE (fatigue), MYALGIA (body aches), HEADACHE (Headache) and LYMPHADENITIS (swelling under the armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment products included Tylenol, Advil.
The day after my second dose of the covid19 vaccine, I developed itchiness all over my body. It itches everywhere, every day, all the time. Feels like I have ants crawling on me all the time, it is so intense it sometimes wakes me up at night. There is no rash, no welts, no redness, just intense itching that moves around my body. Chest, back, thighs, legs, feet, arms, shoulders, scalp, face. antihistamines have no effect (Benadryl, Zyrtech, diphenhydramine), OTC itch cream and Calamine lotion do not work. Cool showers work briefly.  I have never before experienced anything like this.
About 45 minutes after 2nd shot I had very odd feeling of lightheaded and dizzy.  Also felt like a tight band around chest and difficulty in a deep breath.  This lasted about 20 minutes.  Since then a lot of joint pain  and fatigue
Worse side effects with the second dose than with the first dose; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Worse side effects with the second dose than with the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Worse side effects with the second dose than with the first dose). At the time of the report, ADVERSE EVENT (Worse side effects with the second dose than with the first dose) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  No Concomitant medication were reported.  No treatment medication were reported.
aching in neck; aching in his arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (aching in his arm) and NECK PAIN (aching in neck) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no adverse events).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (aching in his arm). On an unknown date, the patient experienced NECK PAIN (aching in neck). At the time of the report, PAIN IN EXTREMITY (aching in his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication and treatment provided
This spontaneous report as received from a medical assistant concerning multiple unspecified patients. On an unknown date the patients were vaccinated with multiple doses of improperly stored VAQTA lot # M027879, expiration date 24-JAN-2018 and M036459 expiration date 18-JAN-2018 for prophylaxis. The temperature was 32°F to 35°F for 72 hours. No adverse events and no product quality complaint were reported. This is one of several reports from the same source.; Sender's Comments: US-009507513-1707USA000692: US-009507513-1706USA010023: US-009507513-1707USA000691:
35 y.o female present to the ER  after receiving the first dose to her COVID 19 vaccine. Initially experiencing a metallic taste in her mouth, palpitations, and nausea. She felt lightheaded but did not lose consciousness. Her symptoms rapidly improved. Her vital signs remained normal.
Agitation, Palpitations, HYPERtension, Tachycardia,  Anxiety, clammy skin, nervousness  Narrative:  Employee with history of severe anxiety, panic attacks. States this is same symptoms as panic attack.
Information has been received from a registered nurse concerning an 8 week old female infant with dermatitis and congestion on the day of vaccination who on 06-DEC-2007 was vaccinated intramuscularly a 0.5 mL dose of with a dose of Hib conj vaccine (OMPC) (lot 657395/0819U). The patient was concomitantly vaccinated with PEDIARIX and PREVNAR. The nurse reported that the patient's mother contacted the office and stated that the patient seemed to cry a lot the third day post vaccination. The nurse did not think that the crying was related to the vaccine. The patient recovered by the following day. Additional information has been requested. This is in follow-up to report (s) previously submitted on 2/18/2008. The nurse did not think that the crying was related to the vaccine and reported that the patient did not have any ill effects from the vaccine. No furher information is available.
pt recv vax OCT96 & 23DEC96 pt started having a fever, vomiting, & diarrhea;pt has recovered;
pt recv vax 7JUL97 & 2 days p/vax 9JUL pt exp fever 99.5, vomiting & myalgia;after 1wk pt was reported to be losing weight,has chills, fever & is still vomiting;
Febrile, neutropenic, thrombocytopenic illness w/ fatigue and malaise. Observed 3 days in hospital. Made spontaneous recovery; Vaccine NDC: 58160-842-52; Exp.: 07/05/2019.
COVID-19 PFIZER GRAY TOP WAS DILUTED WITH 1.8 ML OF DILUENT IN ERROR PATIENT RECEIVED DILUTED DOSE
a flare up; Dry mouth; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP) for a Pfizer sponsored program.  A 55 year-old female patient (unknown if pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation; tofacitinib citrate (XELJANZ XR), oral (Batch/Lot number: unknown) at 11 mg daily. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Hydrocodone, reaction(s): "Allergies: HYDROCODONE". The following information was reported: CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "a flare up"; DRY MOUTH (non-serious), outcome "unknown", described as "Dry mouth". The action taken for tofacitinib citrate was temporarily withdrawn.  Additional information: Patient states had to go off Xeljanz for a week when she got her covid vaccine (Pfizer) and had a flare up while she was on vacation it was miserable. Doctor aware.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Left arm (side of vaccination) is numb with slight tingling sensation. Mind a bit groggy.
ACHE ALL OVER THE BODY; GENERAL FEELING OF BLAH; JOINT PAIN; RASH ON INNER THIGHS AND INNER ARMS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 212AZIA, expiry: UNKNOWN) dose was not reported, administered on 28-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On SEP-2021, the patient experienced rash on inner thighs and inner arms. On an unspecified date, the patient experienced ache all over the body, general feeling of blah, and joint pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the rash on inner thighs and inner arms, joint pain, ache all over the body and general feeling of blah was not reported. This report was non-serious.
5Oct95 Pt recv vax. Jan98 Pt devel chickenpox.Normal course,no secondary complications.3 siblings similar exp.(WAES98011240, 98011483, 98011484).
Arrived at emergency department complaining of fatigue, upper epigastric pain, and pain in ne Patient admitted to the emergency room.  Vital signs obtained.  EKG obtained.  Lab obtained.  GI cocktail given.  Saline lock started.  Protonix 40mg IV given x1.  Patient states epigastric pain went from a rating of 8/10 down to 0.5/10.  Patient then placed in treatment room to await cardiac enzymes 90 minutes after initial along with EKG.  In treatment room patient was given 1-L of normal saline IV bolus x1. Ofirmev 1,000mg IV given x 1.  Heparin 5000 units IV push given x1.  Heparin IV drip started at 1000 units an hour.   ASSESSMENT AND PLAN: 1.      Epigastric pain 2.      Elevated troponin   Initick and shoulder area.
doses administered after excursion; No adverse event; Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) in a 69-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 26-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion).    Concomitant medications details were not reported by the reporter.  Reportedly, Pharmacist called to discuss a temperature excursion that occurred several days ago in the freezer. the excursion was found out in an audit and all the vaccines were viable.  Treatment details were not reported by the reporter.
"small burning sensation in throat", mild numbness in left side of tongue, mild headache Narrative:
Patient states he broke out in hives, noted redness and itching to neck, arms and back approximately 30 mins. after receiving the vaccine. TX. = BENADRYL 50mg IM, CELESTONE 6mg IM.
The patient experienced redness and swelling of R arm around the area of the Proquad injection
Swelling and redness at left upper leg. Redness extends from knee to hip and hot to touch. Extreme fussiness from child. She cries whenever leg is touched. Mom to give Tylenol and apply cold compress. Whole thigh from knee to hip involved.
Patient stated they thought they may be having an allergic reaction to vaccine. Small rash/hives on (L) arm. Was given 25 mg of Benadryl  and water and observed for 30 minutes. Patient stated feeling fine afterwards